Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 6/20 | 0.64 |
| ▸ | MEN1 | O00255 | 2/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.64 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.50 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.50 |
| ▸ | ASIC3 | Q9UHC3 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | NPC1 | O15118 | 4/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.46 |
| ▸ | HPGD | P15428 | 3/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | IDO1 | P14902 | 1/20 | 0.43 |
| ▸ | METAP2 | P50579 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3630556 | 0.89 | IDO1 (0.50) | RAB9AMEN1KMT2AALDH1A1NPC1 | |
| SCHEMBL12999272 | 0.89 | RAB9A (0.55) | RAB9AMEN1KMT2AENPP3ENPP1 | |
| SCHEMBL6351866 | 0.87 | IDO1 (0.48) | RAB9AMEN1KMT2AALDH1A1NPC1 | |
| SCHEMBL14198195 | 0.86 | RAB9A (0.47) | RAB9AMEN1KMT2AENPP3ENPP1 | |
| SCHEMBL24105875 | 0.86 | MEN1 (0.67) | RAB9AMEN1KMT2AENPP3ENPP1 | |
| SCHEMBL14198197 | 0.85 | MEN1 (0.80) | RAB9AMEN1KMT2AASIC3ALDH1A1 | |
| SCHEMBL12853988 | 0.83 | MEN1 (0.76) | RAB9AMEN1KMT2AASIC3ALDH1A1 | |
| SCHEMBL19831020 | 0.83 | MAOB (0.46) | RAB9AMEN1KMT2AALDH1A1NPC1 | |
| SCHEMBL15460381 | 0.82 | NPC1 (0.49) | RAB9AMEN1KMT2AENPP3ENPP1 | |
| SCHEMBL13203322 | 0.82 | MEN1 (0.46) | RAB9AMEN1KMT2AENPP3ENPP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2802594-B1 | METAL COMPLEXES WITH DIBENZO[F,H]QUINOXALINES | UDC IRELAND LTD (IE) | 2017-04-19 | — | — | EP | disclosed |
| EP-1966343-B1 | ELECTROLUMINESCENT METAL COMPLEXES WITH TRIAZOLES | UDC IRELAND LTD (IE) | 2017-04-19 | — | — | EP | disclosed |
| US-20100044688-A1 | ELECTROLUMINESCENT METAL COMPLEX | CIBA CORPORATION (US) | 2010-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100044688-A1 | ELECTROLUMINESCENT METAL COMPLEX | LDHA, LDHB, NRP1 | RAB9A 4593/4885MEN1 1969/4885KMT2A 3577/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.